Noxopharm (ASX:NOX) advances study for NOXCOVID

Latest Company News - Finance News Network

English - January 12, 2021 13:00 - 54 seconds - 1000 KB
Business News News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Nuheara's (ASX:NUH) earbuds launched by US company HP

Next Episode: Cardinal Resources (ASX:CDV) directors accept Shangong Gold offer

13 Jan 2021 - Drug development company, Noxopharm (ASX:NOX) reports that the latest formal review by the NOXCOVID-1 Safety Steering Committee has cleared it to advance to the fifth and final dosage cohort.